Aurora Cannabis Inc. (ACB) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 40-F for FY2025, filed Jun 18, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ACB SEC filings page.
Aurora Cannabis Inc. (ACB) reported $238.7M in revenue for fiscal year 2025, up 19.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Aurora Cannabis Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Aurora Cannabis Inc. has an operating margin of 1.4%, meaning the company retains $1 of operating profit per $100 of revenue. Among its peers this margin ranks in the lower range, for a profitability score of 16/100. This is up from -16.7% the prior year.
Aurora Cannabis Inc.'s revenue surged 19.9% year-over-year to $238.7M, reflecting rapid business expansion. This strong growth earns a score of 79/100.
Aurora Cannabis Inc. carries a low D/E ratio of 0.07, meaning only $0.07 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 83/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 4.31, Aurora Cannabis Inc. holds $4.31 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 89/100.
Aurora Cannabis Inc. generates a 0.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 24/100. This is up from -12.4% the prior year.
Aurora Cannabis Inc. scores -8.65, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $4.4B against total assets of $593.0M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Aurora Cannabis Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Aurora Cannabis Inc. generates $10.06 in operating cash flow ($11.1M OCF vs $1.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Aurora Cannabis Inc. earns $1.27 in operating income for every $1 of interest expense ($3.4M vs $2.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Not reported for Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Cash & Balance Sheet
Aurora Cannabis Inc. held $95.9M in cash against $28.0M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
ACB Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2540-F | Q3'2540-F | Q2'2540-F | Q1'2540-F | Q4'2440-F | Q4'2340-F | Q1'2340-F | Q1'2240-F |
|---|---|---|---|---|---|---|---|---|
| Gross Profit | N/A | N/A | N/A | $31.4M | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | -$717K | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | $1.3M | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | $2.7M | N/A | N/A | N/A | N/A |
| EPS (Basic) | -$0.24 | N/A | N/A | $0.07 | N/A | N/A | $0.00 | N/A |
| EPS (Diluted) | -$0.24 | N/A | N/A | $0.07 | N/A | N/A | $0.00 | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, R&D Expenses, SG&A Expenses, EBITDA, Income Tax, Diluted Shares (Avg).
ACB Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2540-F | Q3'2540-F | Q2'2540-F | Q1'2540-F | Q4'2440-F | Q4'2340-F | Q1'2340-F | Q1'2240-F |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $593.0M-4.3% | $598.8M | $597.6M | $611.9M | $619.4M-9.6% | $684.9M | $842.5M-59.9% | $2.1B+2.8% |
| Current Assets | $332.7M+5.6% | $339.3M | $307.9M | $319.9M | $315.1M-11.2% | $354.8M | $578.9M+7.8% | $536.8M+75.0% |
| Cash & Equivalents | $95.9M-4.6% | $92.1M | $79.6M | $101.0M | $100.5M-46.8% | $189.0M | $340.1M+0.1% | $339.8M+185.2% |
| Inventory | $130.7M+23.2% | $129.7M | $125.4M | $119.9M | $106.1M+35.2% | $78.5M | $90.2M-4.8% | $94.7M-5.1% |
| Accounts Receivable | $29.5M-11.9% | N/A | N/A | N/A | $33.5M+9.7% | $30.6M | $36.5M-19.5% | $45.4M+14.1% |
| Goodwill | $30.5M-4.3% | N/A | N/A | N/A | $31.9M+130.5% | $13.8M | $0-100.0% | $715.7M+5.0% |
| Total Liabilities | $169.7M-2.9% | N/A | N/A | N/A | $174.9M-41.5% | $299.2M | $327.9M-28.3% | $457.1M-5.2% |
| Current Liabilities | $77.1M-16.2% | N/A | N/A | N/A | $92.0M-47.6% | $175.8M | $101.7M+8.4% | $93.8M-53.1% |
| Non-Current Liabilities | $92.6M+11.8% | N/A | N/A | N/A | $82.9M-32.9% | $123.4M | $226.2M-37.7% | $363.3M+28.7% |
| Long-Term Debt | $28.0M+672.7% | N/A | N/A | N/A | $3.6M-86.5% | $26.7M | $0 | N/A |
| Total Equity | $394.4M-4.6% | N/A | N/A | N/A | $413.4M+14.0% | $362.8M | $514.2M-68.7% | $1.6B+4.1% |
| Retained Earnings | -$4.4Bn/m | -$4.4B | -$4.7B | -$4.7B | -$4.7Bn/m | -$4.7B | -$4.7Bn/m | -$3.5Bn/m |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
ACB Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
ACB Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2540-F | Q3'2540-F | Q2'2540-F | Q1'2540-F | Q4'2440-F | Q4'2340-F | Q1'2340-F | Q1'2240-F |
|---|---|---|---|---|---|---|---|---|
| Return on Assets | N/A | N/A | N/A | 0.4% | N/A | N/A | N/A | N/A |
| Current Ratio | 4.31+0.9x | N/A | N/A | N/A | 3.42+1.4x | 2.02 | 5.690.0x | 5.72+4.2x |
| Debt-to-Equity | 0.07+0.1x | N/A | N/A | N/A | 0.01-0.1x | 0.07 | 0.00 | N/A |
| Liabilities-to-Equity | 0.430.0x | N/A | N/A | N/A | 0.42-0.4x | 0.82 | 0.64+0.4x | 0.280.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Aurora Cannabis Inc. ACB | FY2025 | $238.7M | $1.1M | 0.5% | $245.6M | 49/100 |
| Lifecore Biomedical, Inc. LFCR | FY2025 | $128.9M | -$38.7M | -30.0% | $241.5M | 53/100 |
| Alpha Teknova, Inc. TKNO | FY2025 | $40.5M | -$17.3M | -42.6% | $330.2M | 49/100 |
| China SXT Pharmaceuticals, Inc. SXTC | FY2026 | $1.1M | -$6.2M | N/A | $756K | 51/100 |
| Ironwood Pharmaceuticals, Inc. IRWD | FY2025 | $296.2M | $24.0M | 8.1% | $589.9M | 34/100 |
Where Aurora Cannabis Inc. Ranks
Frequently Asked Questions
What is Aurora Cannabis Inc.'s annual revenue?
Aurora Cannabis Inc. (ACB) reported $238.7M in total revenue for fiscal year 2025. This represents a 19.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Aurora Cannabis Inc.'s revenue growing?
Aurora Cannabis Inc. (ACB) revenue grew by 19.9% year-over-year, from $199.1M to $238.7M in fiscal year 2025.
Is Aurora Cannabis Inc. profitable?
Yes, Aurora Cannabis Inc. (ACB) reported a net income of $1.1M in fiscal year 2025, with a net profit margin of 0.5%.
How much debt does Aurora Cannabis Inc. have?
As of fiscal year 2025, Aurora Cannabis Inc. (ACB) had $95.9M in cash and equivalents against $28.0M in long-term debt.
What is Aurora Cannabis Inc.'s gross margin?
Aurora Cannabis Inc. (ACB) had a gross margin of 54.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Aurora Cannabis Inc.'s operating margin?
Aurora Cannabis Inc. (ACB) had an operating margin of 1.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Aurora Cannabis Inc.'s net profit margin?
Aurora Cannabis Inc. (ACB) had a net profit margin of 0.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Aurora Cannabis Inc.'s return on equity (ROE)?
Aurora Cannabis Inc. (ACB) has a return on equity of 0.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Aurora Cannabis Inc.'s operating cash flow?
Aurora Cannabis Inc. (ACB) generated $11.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Aurora Cannabis Inc.'s total assets?
Aurora Cannabis Inc. (ACB) had $593.0M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Aurora Cannabis Inc. spend on research and development?
Aurora Cannabis Inc. (ACB) invested $2.6M in research and development during fiscal year 2025.
What is Aurora Cannabis Inc.'s current ratio?
Aurora Cannabis Inc. (ACB) had a current ratio of 4.31 as of fiscal year 2025, which is generally considered healthy.
What is Aurora Cannabis Inc.'s debt-to-equity ratio?
Aurora Cannabis Inc. (ACB) had a debt-to-equity ratio of 0.07 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Aurora Cannabis Inc.'s liabilities-to-equity ratio?
Aurora Cannabis Inc. (ACB) had a liabilities-to-equity ratio of 0.43 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Aurora Cannabis Inc.'s return on assets (ROA)?
Aurora Cannabis Inc. (ACB) had a return on assets of 0.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Aurora Cannabis Inc.'s P/E ratio?
Aurora Cannabis Inc. (ACB) trades at 222x earnings, its market capitalization divided by $1.1M net income, FY2025. The market capitalization is $245.6M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Aurora Cannabis Inc.'s price-to-sales ratio?
Aurora Cannabis Inc. (ACB) trades at 1.0x sales, its market capitalization divided by $238.7M revenue, FY2025. The market capitalization is $245.6M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Aurora Cannabis Inc.'s Altman Z-Score?
Aurora Cannabis Inc. (ACB) has an Altman Z-Score of -8.65, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Aurora Cannabis Inc.'s Piotroski F-Score?
Aurora Cannabis Inc. (ACB) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Aurora Cannabis Inc.'s earnings high quality?
Aurora Cannabis Inc. (ACB) has an earnings quality ratio of 10.06x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Aurora Cannabis Inc. cover its interest payments?
Aurora Cannabis Inc. (ACB) has an interest coverage ratio of 1.27x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Aurora Cannabis Inc.?
Aurora Cannabis Inc. (ACB) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.